Highlights from HBA: Collaboration Is the New Competitive Advantage

At this year’s Healthcare Businesswomen’s Association (HBA) Annual Conference, one message resonated across every room: no one can tackle systemic inequities alone. And this conference provides tools to work together for success. From leadership labs to women’s health breakout sessions to phenomenal keynote speakers – publisher/author Arianna Huffington and Julie Kim from Takeda – this…

At this year’s Healthcare Businesswomen’s Association (HBA) Annual Conference, one message resonated across every room: no one can tackle systemic inequities alone. And this conference provides tools to work together for success.

From leadership labs to women’s health breakout sessions to phenomenal keynote speakers – publisher/author Arianna Huffington and Julie Kim from Takeda – this annual conference provided insights and opportunity for motivated attendees to advance leadership capabilities from college classrooms to the C-suite. I was honored to lead one of the sessions, and I brought back several lessons to share.

Three key takeaways from the 2025 HBA conference:

  • Build empathy into the infrastructure

Listening, trust, and inclusion are not soft skills; they’re strategic ones. The emphasis on empathy resonated throughout the conference. Across the sessions, attendees discussed creating systems that make listening actionable, ensuring every woman’s voice informs leadership, care, research, and policy. The key is creating an environment where women’s voices are heard, valued, and acted upon.

  • Base decisions on authentic experiences

In the session I moderated, “Creating the Infrastructure to Support Closing the Women’s Health Gap,” an incredible panel of leaders: Marina Hong Mealin (Bayer), Kimberly Jones (Butler/Till), and Carmen White (Pfizer) discussed a number of factors that can make progress sustainable and scalable, including the importance of basing decisions on authentic, real-world data. Progress starts when research, care models, and communication are built around real, lived experiences rather than assumptions or algorithms.

  • Be the ally you need, for others

When people with influence open doors for others, the entire healthcare ecosystem benefits. It’s collaboration in action, and a reminder that allyship and advocacy are as essential to progress as innovation and funding. From any level or position, we can all play this role for others in our organizations and communities.

A Shared Future

The spirit of HBA 2025 was clear: empathetic, experience-based collaboration isn’t just a value. It’s a competitive advantage.

At Reverba, that’s the ecosystem we’re building, one where voices connect, insights converge, and every stakeholder has a seat at the table. By turning authentic voices and scientific engagement into actionable insight, we help bridge the gap between research and real-world outcomes.


The Latest

  • Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes
    Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes

    At Patients as Partners 2026, CEO Cheryl Lubbert shared how sustaining patient engagement through organizational change requires intentional design, with systems built to hold as teams, priorities, and programs shift.

  • Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?
    Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?

    AI is becoming a baseline expectation in pharma. At Pharma USA 2026, discussions reflected less focus on whether AI should be used and more on how it is being applied…

  • Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact
    Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact

    Late-stage clinical programs establish the evidence required for regulatory evaluation, but they do not guarantee adoption, access, or commercial performance. Translating that evidence into real-world impact requires patient-centered execution and…